Abeo on go with late-stage study of RDEB gene therapy; shares up 3% [Seeking Alpha]
Abeona Therapeutics Inc. (ABEO)
Last abeona therapeutics inc. earnings: 3/16 04:20 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.abeonatherapeutics.com
Company Research
Source: Seeking Alpha
Healthcare | On the Move Abeo on go with late-stage study of RDEB gene therapy; shares up 3% Dec. 9, 2019 9:49 AM ET Abeona Therapeutics Inc. (ABEO) Douglas W. House Abeona Therapeutics ( +2.7% FDA's sign-off The company is on go to start the late-stage study after the agency removed the clinical hold on the program subsequent to the submission of additional transport stability data on EB-101 to clinical sites. VIITAL's primary endpoint will be the proportion of wounds showing at least 50% healing at month 3 compared to untreated wounds on the same patient. EB-101 has Breakthrough Therapy, Orphan Drug, Rare Pediatric designation and Regenerative Medicine Advanced Therapy status for the indication. See all stocks on the move » Now read: GW Pharmaceuticals Tumbles On Beat, But Its Growth Story Is Only Beginning » Try PREMIUM
Show less
Read more
Impact Snapshot
Event Time:
ABEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABEO alerts
High impacting Abeona Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
ABEO
News
- SHAREHOLDER ALERT: Abeona Therapeutics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the FirmAccesswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEOGlobeNewswire
- Abeona Therapeutics Tanks On CRL From The FDA, But All Hope Is Not Lost [Seeking Alpha]Seeking Alpha
- SHAREHOLDER ALERT: Abeona Therapeutics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the FirmAccesswire
- Abeona Therapeutics Inc (NASDAQ: ABEO) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
ABEO
Sec Filings
- 4/26/24 - Form 4
- 4/26/24 - Form 4
- 4/24/24 - Form 8-K
- ABEO's page on the SEC website